In one study, transgenic mice in which activated β-catenin was expressed specifically in the uterus exhibited high levels of β-catenin accumulation in nuclei, increased expression of c-myc and cyclin D1, increased glandular proliferation, and extensive hyperplasia – but no cancer within the first year of life [53]. This evidence concerns the gene MYC and cancer.